Popular on eTradeWire
- Plan Heal Smart Health Assessment Platform Now Available in the Microsoft Azure Marketplace - 537
- Impress from Engagis Now Available in the Microsoft Azure Marketplace - 293
- enCloud9 Partners with ClickDimensions to Launch PowerPack, Revolutionizing Sales and Marketing for SMBs - 267
- Gravic, Inc. is Pleased to Announce the General Availability of HPE NonStop Shadowbase Version 6.801 - 245
- BOWA Gives Girls' Invite track and field competition to be held in Chicago's Pullman neighborhood - 232
- IAM and Universiti Malaya form collaborative relationship/ MOU - 183
- Unlocking the Magic of Miami Beach - 156
- Expert Writer Melanie Green to Host The Freelance Writing Podcast - 130
- The New Way of Selling Your House! - 127
- Local Speaker and Humanitarian Travels to England for Faces of Women of Heart Awards - 120
Similar on eTradeWire
- Ayda Announces Launch of USD Participant Payouts and Increases Coverage to 52 Countries
- Aquareyn Acquires Assets of Thar Process, Inc
- Actuated Medical Expands Expertise in Forensic DNA Analysis with Acquisition of Mitotyping Technologies LLC
- Argentum Medical announces plans to expand the company's presence in Saudi Arabia
- Innovative Marketing and Branding Services Tailored for Small Clinics and Pharmacies
- Transitions Healthcare, LLC Acquires The Shook Home & The Quarters at Shook in Chambersburg, PA
- VALFIX Medical Inc. Secures Fifth Consecutive Grant from the Israel Innovation Authority
- Dr. George Sepiashvili Was Just Interviewed By Randy Alvarez On The Wellness Hour TV Show!
- QinFlow & First Responders Stand Behind Ukraine!
- TekTone® Donates to Macon County Public Health in Honor of Breast Cancer Awareness
FDA Clears New Laboratory Blood Glucose Reference Analyzer from Nova Biomedical
eTradeWire News/10706108
WALTHAM, Mass. - eTradeWire -- The U.S. Food and Drug Administration (FDA) has cleared Nova Primary as a blood glucose reference analyzer. Nova Primary fills the need for a new glucose reference analyzer to replace the discontinued YSI STAT PLUS 2300 Glucose and L-Lactate analyzer (YSI, Inc., Yellow Springs, OH).
Manufacturers of blood glucose measuring devices and clinical diabetes researchers have relied on the YSI 2300 as a reference and correlation analyzer. However, YSI, Inc. no longer supports the analyzer, and its discontinuation has left a critical industry void. The Nova Primary analyzer fills that need. With today's FDA clearance, Nova Primary is now available in the U.S. and worldwide. According to Matthew McRae, Nova Sales Product Line Manager, "We at Nova Biomedical are pleased to offer the Nova Primary, an accurate, easy-to-use and modernized blood glucose reference analyzer for glucose device manufacturers and clinical diabetes researchers to replace the discontinued YSI Stat Plus glucose analyzer."
More on eTradeWire News
Like the YSI 2300, Nova Primary uses a single, reusable glucose electrochemical sensor based on glucose oxidase and has a measurement range of 20-900 mg/dL. It uses a small, 25 microliter venous whole blood or plasma sample which is internally diluted as in the YSI. Results are available in approximately 2 minutes. Nova Primary's large color touchscreen display and intuitive, icon-based graphical user interface make it very straightforward to use. A single calibrator pack uses RFID data management to monitor the pack expiration date and number of samples remaining, eliminating the need for separate reagent bottles and daily monitoring of their levels. In clinical laboratory studies using venous whole blood and plasma, the Nova Primary demonstrated excellent correlation to the YSI 2300 and is traceable to NIST glucose standards. The Nova Primary uses a comma delimited (.csv) format data output that can be downloaded via the integral USB data port. The analyzer measures 17 in x 11 in x 18 in (44 cm x 28 cm x 46 cm).
More on eTradeWire News
About Nova Biomedical
Incorporated in 1976 and based in Waltham, MA, Nova Biomedical is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers, as well as instruments for cell culture monitoring in the biotechnology market. Nova uses biosensor technology in products ranging from handheld meters for glucose self- and point-of-care testing to critical care whole blood analyzers designed for stat measurement of over 22 analytes. Nova employs over 1,400 people worldwide and has wholly owned subsidiaries located in Benelux, Brazil, Canada, France, Germany, Great Britain, Italy, Japan, Spain, and Switzerland.
Manufacturers of blood glucose measuring devices and clinical diabetes researchers have relied on the YSI 2300 as a reference and correlation analyzer. However, YSI, Inc. no longer supports the analyzer, and its discontinuation has left a critical industry void. The Nova Primary analyzer fills that need. With today's FDA clearance, Nova Primary is now available in the U.S. and worldwide. According to Matthew McRae, Nova Sales Product Line Manager, "We at Nova Biomedical are pleased to offer the Nova Primary, an accurate, easy-to-use and modernized blood glucose reference analyzer for glucose device manufacturers and clinical diabetes researchers to replace the discontinued YSI Stat Plus glucose analyzer."
More on eTradeWire News
- Florida Foot and Ankle Specialists Shed Light on Top Three Common Foot Conditions
- The Hutchinson Prize Provides Dozens of Scholarships to The Most Impoverished Students in Kenya's Huruma District
- Boys & Girls Clubs of Lee County receives $25,000 grant from Kohl's National Giveback Initiative
- It's A Good Time To Invest In A Hutchinson Island Condo
- Metal Building Manufacturers Association Announces 2024 Board of Directors
Like the YSI 2300, Nova Primary uses a single, reusable glucose electrochemical sensor based on glucose oxidase and has a measurement range of 20-900 mg/dL. It uses a small, 25 microliter venous whole blood or plasma sample which is internally diluted as in the YSI. Results are available in approximately 2 minutes. Nova Primary's large color touchscreen display and intuitive, icon-based graphical user interface make it very straightforward to use. A single calibrator pack uses RFID data management to monitor the pack expiration date and number of samples remaining, eliminating the need for separate reagent bottles and daily monitoring of their levels. In clinical laboratory studies using venous whole blood and plasma, the Nova Primary demonstrated excellent correlation to the YSI 2300 and is traceable to NIST glucose standards. The Nova Primary uses a comma delimited (.csv) format data output that can be downloaded via the integral USB data port. The analyzer measures 17 in x 11 in x 18 in (44 cm x 28 cm x 46 cm).
More on eTradeWire News
- Vegas Massacre a Reminder - Most Colleges Still Unprepared For a Shooter
- Ayda Announces Launch of USD Participant Payouts and Increases Coverage to 52 Countries
- Spreading the Twinkl Magic this Festive Season
- Revolutionizing the New Homes Industry
- Michigan Computer Supplies Helps Fix Pesky Printer Problems
About Nova Biomedical
Incorporated in 1976 and based in Waltham, MA, Nova Biomedical is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers, as well as instruments for cell culture monitoring in the biotechnology market. Nova uses biosensor technology in products ranging from handheld meters for glucose self- and point-of-care testing to critical care whole blood analyzers designed for stat measurement of over 22 analytes. Nova employs over 1,400 people worldwide and has wholly owned subsidiaries located in Benelux, Brazil, Canada, France, Germany, Great Britain, Italy, Japan, Spain, and Switzerland.
Source: Nova Biomedical
0 Comments
Latest on eTradeWire News
- Tune In to Fox Business for an Interview with Curtis Cloke America's Leading Retirement Income Expert
- Unveiling the Ethnic Variances of Menopause
- Foreign Car Care Auto Repair Shop in Cedarville, Arkansas
- Exceptional Parent Magazine Provides Free Support and Information for Special Needs Families
- Ayahuasca Near Me in Alabama - Spirit of Truth Native American Church
- Avery Burton Foundation, Las Vegas Raiders Foundation Team Up To Tackle Mental Health Issues; ABF Awarded $25,000 Grant
- Executive Coaching at Hewsons Executive Development, Melbourne, Australia
- Dawn Loves Nash Announces Debut Album Release: A Captivating Musical Journey of Love and Healing
- 8000EMR Series of EMI- and RFI-Resistant Liquid Flow Meters
- Greg Lindberg Explores in Latest Book the Science of Quantum Biology and Its Impact on Human Life
- Benchmark International Successfully Facilitated The Transaction BT Mission Data, LLC And Growth
- Cuebiq Soars High as EMEA's 2023 AWS Partner of the Year
- Roger Williams University Named a National Center of Academic Excellence in Cyber Defense
- Muller Law Firm Explains the Importance of Documentation in Credit and Collection
- A Maui Luxury Real Estate Agent can Help Buy and Sell in Maui
- Howell-Based Lawn Care Company Shares Tips for Winter
- Catch the Exciting 39th Annual Kingdom Day Parade in Los Angeles Exclusively on ABC 7!
- Alumi-Span Docks Helps You Transform Your Dock into an Outdoor Living Space
- Plan Heal Smart Health Assessment Platform Now Available in the Microsoft Azure Marketplace
- The 30 Second Dance Party Volume II: Elevating Joy in Classrooms, Offices, and Homes